• No results found

Collateral sensitivity in clinical Escherichia coli isolates

N/A
N/A
Protected

Academic year: 2022

Share "Collateral sensitivity in clinical Escherichia coli isolates"

Copied!
79
0
0

Laster.... (Se fulltekst nå)

Fulltekst

(1)
(2)
(3)
(4)
(5)
(6)
(7)
(8)
(9)
(10)

µg

(11)
(12)

β

(13)
(14)
(15)
(16)
(17)

β

(18)
(19)
(20)
(21)

µ

-

-

-

(22)
(23)
(24)
(25)
(26)

µ

µ

(27)
(28)
(29)
(30)
(31)
(32)
(33)
(34)

(35)

-

-

-

-

-

-

(36)
(37)
(38)
(39)
(40)
(41)
(42)
(43)
(44)

µ

µ

(45)
(46)
(47)
(48)

µ

(49)
(50)
(51)
(52)

µg

(53)
(54)
(55)

32x 16x 8x 4x 2x 0 2x 4x 8x 16x 32x

Sensitivity MIC WT Resistance

(56)

32x 16x 8x 4x 2x 0 2x 4x 8x 16x 32x

Sensitivity MIC WT Resistance

(57)

32x 16x 8x 4x 2x 0 2x 4x 8x 16x 32x

Sensitivity MIC WT Resistance

32x 16x 8x 4x 2x 0 2x 4x 8x 16x 32x

Sensitivity MIC WT Resistance

(58)
(59)
(60)
(61)
(62)
(63)

β

(64)
(65)
(66)
(67)
(68)
(69)
(70)
(71)
(72)
(73)
(74)
(75)
(76)
(77)
(78)
(79)

Referanser

RELATERTE DOKUMENTER

Both agar well diffusion and agar disk diffusion test showed no sensitivity towards mecillinam, regardless of which media was used; induction of mrd with IPTG did not make

Clinical and bacteriological efficacy of pivmecillinam treatment for un- complicated urinary tract infections caused by ESBL-producing Escherichia coli : a

35 Table 10: Table of TP+CIP double mutants and their MICs for each antibiotic. The MIC of ciprofloxacin in TP mutants was expected to be the same as for the MIC determined

To further investigate the impact of plasmid acquisition, we studied the conjugation frequency, fitness cost and stability of a ~145 kb IncC bla NDM-1 -encoding clinical plasmid in

Prevalence of antibiotic-resistant isolates of Escherichia coli and all Enterobacteriaceae species combined (including E. coli) in the first and the last faecal sample from

Antimicrobial resistant Escherichia coli (n=331) isolates from humans with bloodstream in- fections were investigated for the presence of class 1 and class 2 integrons.. The

Clinical and bacteriological efficacy of pivmecillinam treatment for uncomplicated urinary tract infections caused by ESBL- producing Escherichia coli: a prospective,

The population structure of human carriage and clinical isolates of ESBL-producing Escherichia coli and Klebsiella pneumoniae in Norway..